<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bone</journal-id><journal-id journal-id-type="iso-abbrev">Bone</journal-id><journal-title-group><journal-title>Bone</journal-title></journal-title-group><issn pub-type="ppub">8756-3282</issn><issn pub-type="epub">1873-2763</issn><publisher><publisher-name>Elsevier Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31056460</article-id><article-id pub-id-type="pmc">6548283</article-id><article-id pub-id-type="publisher-id">S8756-3282(19)30158-9</article-id><article-id pub-id-type="doi">10.1016/j.bone.2019.04.020</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Corrigendum to &#x0201c;Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells&#x0201d; [Bone 122 (May 2019) 82&#x02013;92]</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Faraahi</surname><given-names>Z.</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Baud'huin</surname><given-names>M.</given-names></name><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Croucher</surname><given-names>P.I.</given-names></name><xref rid="af0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Eaton</surname><given-names>C.</given-names></name><xref rid="af0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Lawson</surname><given-names>M.A.</given-names></name><email>m.a.lawson@sheffield.ac.uk</email><xref rid="af0020" ref-type="aff">d</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib></contrib-group><aff id="af0005"><label>a</label>Institute for Cancer Sciences, University of Manchester, UK</aff><aff id="af0010"><label>b</label>INSERM U957, EA 3822, Nantes, France</aff><aff id="af0015"><label>c</label>Bone Biology Division, Garvan Institute of Medical Research, Sydney, Australia</aff><aff id="af0020"><label>d</label>Department of Oncology and Metabolism, Medical School, University of Sheffield, UK</aff><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author at: Department of Oncology &#x00026; Metabolism, School of Medicine and Biomedical Sciences, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. <email>m.a.lawson@sheffield.ac.uk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>7</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>7</month><year>2019</year></pub-date><volume>124</volume><fpage>166</fpage><lpage/><permissions><copyright-statement>&#x000a9; 2019 The Author(s)</copyright-statement><copyright-year>2019</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><related-article related-article-type="corrected-article" id="d31e12" ext-link-type="doi" xlink:href="10.1016/j.bone.2019.02.012"/></article-meta></front><body><p id="p0005">The authors regret that the original published acknowledgements were not complete. They should have read:</p><p id="p0010">&#x0201c;The authors wish to thank in <funding-source id="gts0005">Bloodwise</funding-source> (formerly Leukaemia and Lymphoma Research) UK for their generous financial support for this work. ZF was also supported by an <funding-source id="gts0010">MRC</funding-source> UK studentship. We would also like to thank Dr Clive Buckle for his early gene expression studies on murine myelomas, which provided a preliminary identification of Sostdc1, as a gene of potential interest in myeloma-induced bone disease.&#x0201d;</p><p id="p0015">The authors would like to apologise for any inconvenience caused.</p></body></article>